National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Soft Tissue Sarcoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 12/05/2008
Table 2. AJCC Staging System for Soft Tissue Sarcomasa

  Primary Tumorb  Regional Lymph Nodes  Distant Metastasis  Histologic Gradec 
Stage I Any tumor size, superfical or deep N0 M0 G1
G2
Stage II T1a (tumor ≤5 cm in maximal diameter, superficial) N0 M0 G3
T1b (tumor ≤5 cm in maximal diameter, deep) N0 M0 G3
T2a (tumor >5 cm in maximal diameter, superficial) N0 M0 G3
Stage III T2b (tumor >5 cm in maximal diameter, deep) N0 M0 G3
Stage IV Any tumor size, superfical or deep N1 M0 or M1 G1, G2, or G3
Any tumor size, superfical or deep N0 or N1 M1 G1, G2, or G3

G1 = well differentiated; G2 = moderately differentiated; G3 = poorly differentiated; M0 = no distant metastasis; M1 = distant metastasis; N0 = no regional lymph node metastasis; N1 = regional lymph node metastasis
aAdapted from AJCC Cancer Staging Manual.[10]
bSuperficial tumor is located above the superficial fascia without invasion of the fascia; deep tumor is located either exclusively beneath the superficial fascia or superficial to the fascia with invasion of or through the fascia. All intraperitoneal visceral lesions, retroperitoneal, pelvic, and intrathoracic tumors, and the majority of head and neck tumors are classified as deep tumors.
cThe histologic grade established by central pathology review is to be used for staging purposes.

References

  1. American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002. 


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov